NCAM1 | Neural cell adhesion molecule 1 | Cancer-related genes CD markers Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
NCS1 | Neuronal calcium sensor 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
NES | Nestin | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
NPY | Neuropeptide Y | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
NQO1 | NAD(P)H dehydrogenase, quinone 1 | Cancer-related genes Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
OAT | Ornithine aminotransferase | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
OCLN | Occludin | Disease related genes Potential drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
OXCT1 | 3-oxoacid CoA transferase 1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
PEG10 | Paternally expressed 10 | Predicted intracellular proteins
| | | | | Group enriched |
PLCB3 | Phospholipase C, beta 3 (phosphatidylinositol-specific) | Enzymes Predicted intracellular proteins
| | | | | Group enriched |
PTGES | Prostaglandin E synthase | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
PTGS1 | Prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) | Cancer-related genes Enzymes FDA approved drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
RENBP | Renin binding protein | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
S100B | S100 calcium binding protein B | Cancer-related genes Candidate cardiovascular disease genes Predicted intracellular proteins
| | | | | Group enriched |
SATB2 | SATB homeobox 2 | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
SCGN | Secretagogin, EF-hand calcium binding protein | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
SGOL2 | Shugoshin-like 2 (S. pombe) | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
SLC2A1 | Solute carrier family 2 (facilitated glucose transporter), member 1 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SOAT1 | Sterol O-acyltransferase 1 | Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enriched |
SPTB | Spectrin, beta, erythrocytic | Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
SV2A | Synaptic vesicle glycoprotein 2A | FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enriched |
TFAP2C | Transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma) | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
TOP2A | Topoisomerase (DNA) II alpha 170kDa | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
UCHL1 | Ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enriched |
VIL1 | Villin 1 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
WAS | Wiskott-Aldrich syndrome | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
ZNF185 | Zinc finger protein 185 (LIM domain) | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |